Get the Stockscreener App
0.00
100.00%
-0.065
Tff Pharmaceuticals Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.
See More
Previous Close:
$0.065
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$288.80K
Revenue:
-
Net Income/Loss:
$-19.93M
P/E Ratio:
0.00
EPS:
-9.75
Net Cash Flow:
$-14.82M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.23
Tff Pharmaceuticals Inc Stock (TFFP) Company Profile
Name
Tff Pharmaceuticals Inc
Sector
Industry
Phone
737-802-1973
Address
2600 VIA FORTUNA, SUITE 360, AUSTIN
Compare TFFP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TFFP
Tff Pharmaceuticals Inc
|
0.00 | 288.80K | 0 | -19.93M | -14.82M | -9.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Tff Pharmaceuticals Inc Stock (TFFP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-22 | Resumed | H.C. Wainwright | Buy |
| Feb-08-21 | Initiated | H.C. Wainwright | Buy |
| Dec-07-20 | Initiated | B. Riley Securities | Buy |
| Aug-17-20 | Reiterated | Maxim Group | Buy |
| Jul-08-20 | Initiated | Maxim Group | Buy |
Tff Pharmaceuticals Inc Stock (TFFP) Latest News
Airbus Stays Steady Despite Tariff Troubles, TF1 And TP Show Mixed Signals - Finimize
Aspergillosis Market Expected to Rise by 2034, Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, - Barchart.com
Eastman Chemical's Earnings Surpass Estimates, Sales Miss in Q1 - The Globe and Mail
LKQ (LKQ) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Head-To-Head Contrast: NeuroSense Therapeutics (NASDAQ:NRSN) versus TFF Pharmaceuticals (NASDAQ:TFFP) - Defense World
Northrop Grumman (NOC) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Aspergillosis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail
Aspergillosis Market on Track for Major Expansion by 2034, - openPR.com
Aspergillosis Market on Track for Major Expansion by 2034, According to DelveInsight | F2G, Pulmatrix, TFF Pharmaceuticals, Scynexis, Pulmocide - The Globe and Mail
If You Had Invested $1,000 in ServiceNow Stock 10 Years Ago, Here's How Much You Would Have Today - The Globe and Mail
TFF Pharmaceuticals approves dissolution plan By Investing.com - Investing.com South Africa
TFF Pharmaceuticals approves dissolution plan - Investing.com India
Tff Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends - The Globe and Mail
Pre-market Movers: PALI, KROS, AVGR, TRVI... - RTTNews
TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration - Yahoo Finance
TFF Pharmaceuticals to Exit Nasdaq: Complete Liquidation Plan Leaves Shareholders in Limbo - Stock Titan
Updated Zoetis label for Librela ‘a relief,’ says Piper Sandler - MSN
Tonix Pharmaceuticals promotes Fogarty to CTO - MSN
TFF Pharmaceuticals authorizes special share issuance By Investing.com - Investing.com Canada
TFF Pharmaceuticals authorizes special share issuance - MSN
TDG Gold upsizes non-brokered private placement - MSN
Larimar started at buy by Truist on Friedreich's ataxia drug - MSN
Inhalable Drugs Market Poised for Strong Growth: Unpacking the Emerging Trends, Key Players and Market Forecasts - openPR
Takeda-backed Ascentage Pharma prices $126M U.S. IPO - MSN
Lung Transplant Rejection Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | Kamada, Genentech, Bristol Myers Squibb, MimeTech, Corline Biomedical - Barchart
Lung Transplant Rejection Pipeline 2024: In-depth Clinical - openPR
Aspergillosis Market Expected to rise, 2034 | Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, I - The Globe and Mail
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN
UBI Pharma Inc. - Contract Pharma
Thin Film Drug Manufacturing Market in 2024: Thin Film Drug Innovations Enhance Compliance And Effectiveness - EIN News
McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales - MSN
United States shares lower at close of trade; Dow Jones Industrial Average down 0.53% - Investing.com India
TFFP Stock Plummets to 52-Week Low of $0.21 Amid Market Struggles - Investing.com Australia
Nasdaq Down 50 Points; US Initial Jobless Claims Rise - Benzinga
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket - Benzinga
TFFP Stock Plummets to 52-Week Low of $0.21 Amid Market Struggles By Investing.com - Investing.com South Africa
Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast - Benzinga
U.S. STOCKS Candel Therapeutics, Broadcom, Reddit - XM
Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations - Benzinga
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
TFF Pharmaceuticals to be delisted from Nasdaq - Investing.com
TFF Pharmaceuticals to be delisted from Nasdaq By Investing.com - Investing.com Nigeria
Selling Your Tff Pharmaceuticals Inc (NASDAQ: TFFP) Stock? Here’s What You Need To Know - Stocks Register
What You Didn’t Know About WW International Inc (NASDAQ: WW) This Week - Stocks Register
United States shares lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN
TFF Pharmaceuticals IncOrdinary Shares (TFFP) reports earnings - Quartz
TFF Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
TFF Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN
TFF Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - Marketscreener.com
Tff Pharmaceuticals Inc Stock (TFFP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
2.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):